Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
Derong Huang, Zhongxiu Chen, Jie Wang, et al.
Bioscience Reports (2020) Vol. 40, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Circulating microRNAs: Biomarkers of disease
Yudong Wu, Qian Li, Renshuai Zhang, et al.
Clinica Chimica Acta (2021) Vol. 516, pp. 46-54
Closed Access | Times Cited: 127
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 52
Down-Regulated Exosomal MicroRNA-221 – 3p Derived From Senescent Mesenchymal Stem Cells Impairs Heart Repair
Ling Sun, Wenwu Zhu, Pengcheng Zhao, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 78
A systematic review of microRNAs in patients with hypertrophic cardiomyopathy
Fernando Luís Scolari, Lucas Simonetto Faganello, Henrique Iahnke Garbin, et al.
International Journal of Cardiology (2020) Vol. 327, pp. 146-154
Closed Access | Times Cited: 34
Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy
G. A. Burnasheva, R. P. Myasnikov, О. В. Куликова, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 22, Iss. 12, pp. 3839-3839
Open Access | Times Cited: 3
MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
Enrica Chiti, Marco Di Paolo, Emanuela Turillazzi, et al.
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1720-1720
Open Access | Times Cited: 21
The lncRNA ADAMTS9-AS1/miR-185-5p/KAT7 ceRNA network inhibits cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy
Bangrong Song, Wei Li, Xiaoyu Xu, et al.
Biomedical Research (2023) Vol. 44, Iss. 3, pp. 105-115
Open Access | Times Cited: 8
Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways
Lusha W. Liang, Kohei Hasegawa, Matthew J. Maurer, et al.
Circulation Heart Failure (2023) Vol. 16, Iss. 6
Open Access | Times Cited: 7
Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
Chen Zhang, Hongbo Zhang, Lei Zhao, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1978-1978
Open Access | Times Cited: 9
Plasma and Myocardial miRNomes Similarities and Differences during Cardiac Remodelling and Reverse Remodelling in a Murine Model of Heart Failure with Preserved Ejection Fraction
Sara-Ève Thibodeau, Emylie-Ann Labbé, Élisabeth Walsh‐Wilkinson, et al.
(2024)
Open Access | Times Cited: 1
Cardiomyopathies: The Role of Non-Coding RNAs
Nicole Carabetta, Chiara Siracusa, Isabella Leo, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 6, pp. 53-53
Open Access | Times Cited: 1
Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy
Kristina Sonnenschein, Jan Fiedler, David de Gonzalo‐Calvo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Circulating mRNA and microRNA profiling analysis in patients with ischemic stroke
Sujuan Sun, Litao Li, Lipeng Dong, et al.
Molecular Medicine Reports (2020) Vol. 22, Iss. 2, pp. 792-802
Open Access | Times Cited: 9
Correlation between decreased plasma miR-29a and vascular endothelial injury induced by hyperlipidemia
Lina An, Liming Gao, Min Ning, et al.
Herz (2022) Vol. 48, Iss. 4, pp. 301-308
Closed Access | Times Cited: 5
The Overexpression of miR-377 Aggravates Sepsis-Induced Myocardial Hypertrophy by Binding to Rcan2 and Mediating CaN Activity
Shiji Wang, Guang Wang, Lihua Dong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 4
Cardiomyopathies in China: A 2018–2019 state‐of‐the‐art review
Tianrui Hua, Shuyang Zhang
Chronic Diseases and Translational Medicine (2020) Vol. 6, Iss. 4, pp. 224-238
Open Access | Times Cited: 4
Influence of miR-221/222 on cardiomyocyte calcium handling and function
Maria Knyrim, Sindy Rabe, Claudia Großmann, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Plasma and Myocardial miRNomes Similarities and Differences during Cardiac Remodelling and Reverse Remodelling in a Murine Model of Heart Failure with Preserved Ejection Fraction
Sara-Ève Thibodeau, Emylie-Ann Labbé, Élisabeth Walsh‐Wilkinson, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 892-892
Open Access
Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?
О. С. Чумакова, Е. А. Мершина
Experimental Biology and Medicine (2024) Vol. 249
Open Access
GENETINIŲ TYRIMŲ PRAKTINĖ REIKŠMĖ DIAGNOZUOJANT PAVELDIMAS KARDIOMIOPATIJAS
Dovilė Jančauskaitė, Eglė Sadauskienė, Jūratė Barysienė, et al.
Health Sciences (2020) Vol. 30, Iss. 3, pp. 112-117
Open Access
Page 1

Scroll to top